Functional Exercise Performance in Children With Cerebral Palsy: Is the One-Minute Sit-to-Stand Test an Alternative to the Six-Minute Walk Test
1 other identifier
observational
78
1 country
1
Brief Summary
This study investigates the validity of the 1-minute sit-to-stand test (1MSTS) as a practical and time-efficient alternative to the 6-minute walk test (6MWT) for assessing functional exercise capacity in children with spastic cerebral palsy (CP). Children aged 5 to 18 years with spastic hemiplegic CP, classified as Level I or II according to the Gross Motor Function Classification System (GMFCS), will perform both tests on the same day. Cardiopulmonary responses and fatigue will be monitored before and after each test. The study aims to determine whether the 1MSTS can be reliably used in clinical settings as a simpler assessment tool for this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 10, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedAugust 22, 2025
July 1, 2025
2 months
July 10, 2025
August 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Repetitions in the 1-Minute Sit-to-Stand Test (1MSTS)
This outcome measures the total number of full sit-to-stand movements performed in one minute by participants with spastic hemiplegic cerebral palsy. The aim is to determine whether the 1MSTS is a valid measure of functional exercise performance in this population.
At baseline (single assessment session)
Distance Walked in the 6-Minute Walk Test (6MWT)
Measures the total distance (in meters) walked in 6 minutes by participants on a 30-meter corridor, in accordance with ATS guidelines. The 6MWT serves as the reference test to compare with the 1MSTS.
At baseline (single assessment session)
Secondary Outcomes (4)
Heart Rate (HR) Before and After Exercise Tests
Pre-intervention and immediately after the intervention
Oxygen Saturation (SpO2) Before and After Exercise Tests
Pre-intervention and immediately after the intervention
Systolic and Diastolic Blood Pressure Before and After Exercise Tests
Pre-intervention and immediately after the intervention
Perceived Dyspnea and Leg Fatigue Using Modified Borg Scale
Pre-intervention and immediately after the intervention
Study Arms (1)
Spastic hemiplegic type SP
Individuals between 5 and 18 years of age, diagnosed with spastic hemiplegic type CP and in level I or II according to the Gross Motor Function Classification System (GMFCS) were included.
Eligibility Criteria
The study population consisted of children aged between 5 and 18 years who were diagnosed with spastic hemiplegic type cerebral palsy (CP) and were being followed up at the Physical Therapy and Rehabilitation Clinic of Kayseri City Hospital between December 2024 and July 2025. These individuals were classified as Level I or II according to the Gross Motor Function Classification System (GMFCS), indicating relatively high levels of functional mobility. All participants and their legal guardians were informed about the study's purpose and procedures, and written informed consent was obtained. The study was approved and conducted in accordance with the principles of the Declaration of Helsinki.
You may qualify if:
- Having spastic hemiplegic CP between 5-18
- Being level 1 and 2 according to KMFSS
You may not qualify if:
- Having cognitive/mental problems at a level that may prevent communication
- Having genetic and/or neurological problems in addition to CP
- Having uncontrolled heart disease
- Having any infection Removal Criteria
- The child or his/her parents wanting to leave the study
- Failure to complete the tests to be applied within the scope of the study
- Having an additional disease/surgical operation during the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Inonu Universitylead
- Kayseri Universitycollaborator
Study Sites (1)
Kayseri City Hospital
Kayseri, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- research asistant
Study Record Dates
First Submitted
July 10, 2025
First Posted
August 22, 2025
Study Start
December 31, 2024
Primary Completion
March 1, 2025
Study Completion
July 1, 2025
Last Updated
August 22, 2025
Record last verified: 2025-07